These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21151607)

  • 1. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
    Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
    PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
    Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
    PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen.
    Panza G; Stöhr J; Birkmann E; Riesner D; Willbold D; Baba O; Terashima T; Dumpitak C
    Rejuvenation Res; 2008 Apr; 11(2):365-9. PubMed ID: 18341429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.
    Panza G; Stöhr J; Dumpitak C; Papathanassiou D; Weiss J; Riesner D; Willbold D; Birkmann E
    Biochem Biophys Res Commun; 2008 Sep; 373(4):493-7. PubMed ID: 18585368
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-barrier phenomenon in prion transmissibility from a viewpoint of protein science.
    Hagiwara K; Hara H; Hanada K
    J Biochem; 2013 Feb; 153(2):139-45. PubMed ID: 23284000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.
    Kurt TD; Bett C; Fernández-Borges N; Joshi-Barr S; Hornemann S; Rülicke T; Castilla J; Wüthrich K; Aguzzi A; Sigurdson CJ
    J Neurosci; 2014 Jan; 34(3):1022-7. PubMed ID: 24431459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro.
    Post K; Brown DR; Groschup M; Kretzschmar HA; Riesner D
    Arch Virol Suppl; 2000; (16):265-73. PubMed ID: 11214930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
    Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
    Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic models of prion disease.
    Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
    Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the Bidirectional Properties of the Sheep-Deer Prion Transmission Barrier.
    Harrathi C; Fernández-Borges N; Eraña H; Elezgarai SR; Venegas V; Charco JM; Castilla J
    Mol Neurobiol; 2019 Aug; 56(8):5287-5303. PubMed ID: 30592012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
    Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
    J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion detection by an amyloid seeding assay.
    Colby DW; Zhang Q; Wang S; Groth D; Legname G; Riesner D; Prusiner SB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20914-9. PubMed ID: 18096717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.